Skip to main content

Table 2 The association between GPRC5A and PAAD clinical pathological features

From: IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma

Parameters

GPRC5A(%)

P Value

−

 + 

Gender

 Male

32 (42.5%)

43 (57.5%)

0.579

 Female

50 (46.7%)

57 (53.3%)

Race

 White

93 (59.2%)

64 (40.8%)

0.315

 Black

5 (83.3%)

1 (16.7%)

 Asia

5 (45.5%)

6 (54.5%)

Subdivision

 Head of Pancreas

82 (59.4%)

56 (40.6%)

0.285

 Body of Pancreas

7 (50.0%)

7 (50.0%)

 Tail of Pancreas

7 (46.7%)

8 (53.3%)

Age

 < 60 years

33 (55.2%)

27 (44.8%)

0.472

  ≥ 60 years

74 (60.8%)

48 (39.2%)

Alcohol habit

 No

58 (62.3%)

29 (37.7%)

0.428

 Yes

57 (56.4%)

44 (43.6%)

Grade

 Grade 1

2 (100.0%)

0 (0.00%)

0.031

 Grade 2

24 (77.4%)

7 (22.6%)

 Grade 3

55 (57.9%)

40 (42.1%)

 Grade 4

22 (45.8%)

26 (54.2%)

Stage

 Stage I

17 (81.0%)

4 (19.0%)

0.101

 Stage II

82 (56.8%)

63 (43.2%)

 Stage III

2 (66.7%)

1 (33.3%)

 Stage IV

1 (20.0%)

4 (80.0%)

T

 T1

7 (77.8%)

2 (22.2%)

0.122

 T2

19 (79.2%)

5 (20.8%)

 T3

77 (54.2%)

65 (45.8%)

 T4

2 (66.7%)

1 (33.3%)

N

 N0

34 (61.8%)

21 (38.2%)

0.608

 N1

71 (57.7%)

52 (42.3%)

M

 M0

44 (55.2%)

35 (44.8%)

0.121

 M1

1 (20.0%)

4 (80.0%)